These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8166672

  • 41. ras proteins: biological effects and biochemical targets (review).
    Bar-Sagi D.
    Anticancer Res; 1989; 9(5):1427-37. PubMed ID: 2686537
    [Abstract] [Full Text] [Related]

  • 42. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.
    Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB.
    Science; 1993 Jun 25; 260(5116):1934-7. PubMed ID: 8316833
    [Abstract] [Full Text] [Related]

  • 43. Angiotensin II controls p21ras activity via pp60c-src.
    Schieffer B, Paxton WG, Chai Q, Marrero MB, Bernstein KE.
    J Biol Chem; 1996 Apr 26; 271(17):10329-33. PubMed ID: 8626602
    [Abstract] [Full Text] [Related]

  • 44. [Oncogenes and mitotic signal transduction].
    Tavitian A.
    Pathol Biol (Paris); 1992 Nov 26; 39(9):860. PubMed ID: 1538909
    [No Abstract] [Full Text] [Related]

  • 45. Agents targeting ras signaling pathway.
    Dancey JE.
    Curr Pharm Des; 2002 Nov 26; 8(25):2259-67. PubMed ID: 12369854
    [Abstract] [Full Text] [Related]

  • 46. The dominant negative effects of H-Ras harboring a Gly to Ala mutation at position 60.
    Sung YJ, Hwang MC, Hwang YW.
    J Biol Chem; 1996 Nov 29; 271(48):30537-43. PubMed ID: 8940023
    [Abstract] [Full Text] [Related]

  • 47. Sulindac sulfide inhibits Ras signaling.
    Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, Möröy T, Müller O.
    Oncogene; 1998 Oct 08; 17(14):1769-76. PubMed ID: 9778042
    [Abstract] [Full Text] [Related]

  • 48. Ras-Raf complexes: analyses of complexes formed in vivo.
    Finney R, Herrera D.
    Methods Enzymol; 1995 Oct 08; 255():310-23. PubMed ID: 8524117
    [No Abstract] [Full Text] [Related]

  • 49. Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.
    Mattingly RR, Sorisky A, Brann MR, Macara IG.
    Mol Cell Biol; 1994 Dec 08; 14(12):7943-52. PubMed ID: 7969134
    [Abstract] [Full Text] [Related]

  • 50. Switching nucleotide specificity of Ha-Ras p21 by a single amino acid substitution at aspartate 119.
    Zhong JM, Chen-Hwang MC, Hwang YW.
    J Biol Chem; 1995 Apr 28; 270(17):10002-7. PubMed ID: 7730301
    [Abstract] [Full Text] [Related]

  • 51. The ras gene. Transformer and transducer.
    Hanley MR, Jackson T.
    Nature; 1995 Apr 28; 328(6132):668-9. PubMed ID: 3112584
    [No Abstract] [Full Text] [Related]

  • 52. Activators and effectors of ras p21 proteins.
    McCormick F.
    Curr Opin Genet Dev; 1994 Feb 28; 4(1):71-6. PubMed ID: 8193543
    [Abstract] [Full Text] [Related]

  • 53. The effector interactions of p21ras.
    Marshall MS.
    Trends Biochem Sci; 1993 Jul 28; 18(7):250-4. PubMed ID: 8212134
    [Abstract] [Full Text] [Related]

  • 54. The 3Rs of life: Ras, Raf and growth regulation.
    Moodie SA, Wolfman A.
    Trends Genet; 1994 Feb 28; 10(2):44-8. PubMed ID: 8191584
    [Abstract] [Full Text] [Related]

  • 55. A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.
    DeClue JE, Stone JC, Blanchard RA, Papageorge AG, Martin P, Zhang K, Lowy DR.
    Mol Cell Biol; 1991 Jun 28; 11(6):3132-8. PubMed ID: 2038322
    [Abstract] [Full Text] [Related]

  • 56. Ras effectors and their role in mitogenesis and oncogenesis.
    Joneson T, Bar-Sagi D.
    J Mol Med (Berl); 1997 Aug 28; 75(8):587-93. PubMed ID: 9297626
    [Abstract] [Full Text] [Related]

  • 57. Modulation of the immune response and tumor growth by activated Ras.
    Weijzen S, Velders MP, Kast WM.
    Leukemia; 1999 Apr 28; 13(4):502-13. PubMed ID: 10214854
    [Abstract] [Full Text] [Related]

  • 58. Novel anticancer agents move closer to reality.
    Travis J.
    Science; 1993 Jun 25; 260(5116):1877-8. PubMed ID: 8316828
    [No Abstract] [Full Text] [Related]

  • 59. In vitro cell transformation by ras oncogenes.
    Spandidos DA, Lang JC.
    Crit Rev Oncog; 1989 Jun 25; 1(2):195-209. PubMed ID: 2488130
    [No Abstract] [Full Text] [Related]

  • 60. Regulation of ras p21 by GTPase activating proteins.
    McCormick F, Martin GA, Clark R, Bollag G, Polakis P.
    Cold Spring Harb Symp Quant Biol; 1991 Jun 25; 56():237-41. PubMed ID: 1668082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.